Company Search:
Advanced Search
Sponsored Links
Zoetis Inc Company Snapshot
Zoetis Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zoetis Inc with three other companies in this sector in the United States: Regeneron Pharmaceuticals Incorporated (2015 sales of $4.10 billion of which 100% was Research & Development), Eisai Company Limited ($4.97 billion of which 93% was Pharmaceutical Business), and Perrigo Company PLC ($5.54 billion of which 50% was Consumer Healthcare).

Sales Analysis. During the year ended December of 2015, sales at Zoetis Inc were $4.77 billion. This is a decrease of 0.4% versus 2014, when the company's sales were $4.79 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Zoetis Inc
  Stock Performance Chart for Zoetis Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 53.74
(Figures in U.S. Dollars)
1 Week -0.7%   13 Weeks 2.4%  
4 Weeks 7.1%   52 Weeks 23.9%  
Zoetis Inc Key Data:
  Ticker: ZTS Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 4,765,000,000
(Year Ending Jan 2016).
Employees: 9,000
  Currency: U.S. Dollars Market Cap: 26,560,499,517
  Fiscal Yr Ends: December Shares Outstanding: 494,240,780
  Share Type: Class A Common Closely Held Shares: 955,127
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.